S535-0225 Screening compound: N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide

S535-0225 Screening compound: N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide
S535-0225 Screening compound: N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S535-0225
N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S535-0225

Molecular Formula

C18H26FN3O (C18 H26 FN3 O)

Compound Name

N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide

IUPAC name

N-(3-fluorophenyl)-4-[(pyrrolidin-1-yl)methyl]azepane-1-carboxamide

SMILES

O=C(Nc1cccc(F)c1)N1CCC(CN2CCCC2)CCC1

InChI

InChI=1S/C18H26FN3O/c19-16-6-3-7-17(13-16)20-18(23)22-11-4-5-15(8-12-22)14-21-9-1-2-10-21/h3,6-7,13,15H,1-2,4-5,8-12,14H2,(H,20,23)/t15-/m1/s1

InChI Key

OQFQZJCIGRZUJD-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD31980845

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

319.42

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.005

Distribution Coefficient, logD

-0.119

Water Solubility, LogSw

-3.27

Polar Surface Area

30.137

Acid Dissociation Constant (pKa)

12.15

Base Dissociation Constant (pKb)

10.52

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.11

S535-0225 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with S535-0225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S535-0225?
Check Price and Availability of S535-0225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S535-0225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S535-0225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S535-0225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S535-0225 available by request